What Blue M Tech does

Blue M Tech (주식회사 블루엠텍, KOSDAQ: 439580) operates South Korea's largest AI-powered e-commerce platform for ethical (prescription) drugs, connecting pharmaceutical manufacturers and distributors with hospitals and clinics. Founded in 2015 as BluePharm Korea Co., Ltd. and renamed in 2018 after merging with a big data/IT firm, the company lists over 74,600 prescription drug SKUs and serves roughly 25,000–29,000 active hospital/clinic locations, reportedly covering 63–80%+ of Korea's primary care clinics. Its platform ecosystem includes the BluePharm Korea marketplace with the Blue Me AI administrative assistant, the BOS direct-trading Business Operating System, BlueFeed non-face-to-face MR sales support, BlueDoc doctor recruitment/matching, big data analytics, and a 13,000m² cold-chain fulfillment center in Pyeongtaek certified to EU/WHO/PIC-s GDP and Korean KGSP standards.

The company generates revenue through transaction fees/margins on the BluePharm Korea marketplace, 3PL logistics fees from the BFS fulfillment service, multi-channel medical marketing (display, search, webinars, live broadcasts), and subscription services (BOS, BlueDoc premium headhunting), with selective licensing/royalty income from international technology exports. Its go-to-market is a hybrid platform-B2B model: direct enterprise sales for major pharmaceutical partners (MSD, Sanofi, Bayer, Hanmi, Samsung Biologics, SK Bioscience, Hugel, LG Chem, JW Pharmaceutical) combined with self-serve digital onboarding for thousands of clinics. It has expanded via minority acquisitions in 2024 of telemedicine (MDSquare), cold-chain delivery (Gonggam Plus), and doctor messaging (Medistaff), and is exporting the platform model to Vietnam via an MOU with BuyMed.

Name

Blue M Tech

Legal name

주식회사 블루엠텍

Website

https://bluemtec.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Blue M Tech operates South Korea's largest AI-powered prescription drug e-commerce platform, connecting pharmaceutical manufacturers with roughly 25,000–29,000 hospitals and clinics through its BluePharm Korea marketplace, integrated cold-chain logistics, and digital marketing services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Platform

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG)

Keywords

• Pharmaceutical distribution platform
• Medical e-commerce services
• Cold chain logistics
• Healthcare digital transformation
• Medical marketing solutions

Headquarters

HQ city

Seongnam

HQ country

South Korea

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical e-commerce platform (BluePharm Korea): Revenue from facilitating online transactions of prescription drugs, OTC drugs, medical devices, and beauty/aesthetic products between pharmaceutical companies and hospitals/clinics. BlueMTec takes a margin/commission on transactions processed through the platform.
2. Fulfillment and logistics services (BFS): Third-party logistics (3PL) fulfillment service providing storage (room temperature/refrigerated), pick-pack, shipping, CS, and returns management for pharmaceutical companies and businesses. Revenue is generated through logistics fees based on volume and service scope.
3. Multi-channel medical marketing: Digital marketing services to pharmaceutical companies including display advertising, search advertising, brand halls, web symposiums, live broadcasts (블.라.방), DM/SMS, and SNS marketing, targeting hospitals and clinics on the BluePharm Korea platform.
4. BOS platform services: Direct trading platform services (web order/BOS) for pharmaceutical companies to manage orders and transactions with hospitals/clinics.
5. Medical staffing platform (BlueDoc): Recruitment and job-matching platform revenue, including premium headhunting services for medical staffing needs.
6. International expansion and technology export: Revenue from exporting BluePharm Korea platform technology and cold-chain systems to international markets (e.g., Vietnam through BuyMed partnership) and facilitating Korean pharmaceutical exports.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Blue M Tech operates BluePharm Korea, an AI-powered B2B e-commerce platform connecting pharmaceutical companies with hospitals and clinics for online distribution of prescription drugs, OTC products, medical devices, and aesthetic products. The platform is complemented by a cold-chain pharmaceutical fulfillment service (BFS), multi-channel medical marketing solutions, a non-face-to-face sales support tool (BlueFeed), an AI doctor recruitment platform (BlueDoc), and healthcare big data analytics services.

Product overview

Blue M Tech operates as a healthcare digital transformation platform providing an integrated ecosystem of pharmaceutical e-commerce and related services. The core platform BluePharm Korea serves as the main AI-powered e-commerce marketplace connecting pharmaceutical companies with over 25,000 hospitals and clinics in South Korea. This platform is complemented by fulfillment services (logistics center), multi-channel marketing solutions, sales support tools (BlueFeed), and recruitment solutions (BlueDoc). Key AI-powered features include Blue Me for personalized recommendations, Korean GPT3-based drug search, and BlueStock inventory management. The company also provides big data analytics services based on its accumulated distribution data, targeting both domestic and international pharmaceutical partners.

Differentiator

Problem solved

Functional benefit

Brands

• 블루팜코리아 (BluePharm Korea): AI-powered ethical drug e-commerce platform serving clinics and hospitals
• 블루피드 (BlueFeed)
• 블루닥 (BlueDoc)
• 블루랩스 (Blue Labs)
• 쿨팜 (KoolPharm)

Products and services

• BluePharm Korea (블루팜코리아) AI-powered ethical drug e-commerce platform that connects pharmaceutical companies with hospitals and clinics, providing professional drug purchasing, same-ingredient alternative drug search, and personalized recommendations via Blue Me AI service.
• Fulfillment Service (물류센터/BFS) Cold-chain optimized pharmaceutical fulfillment service providing storage (room temperature, refrigerated, frozen), pick-pack, shipping, customer service, and returns for ethical drugs, cold-chain medicines, cosmetics, and health functional foods. Compliant with EU GDP, WHO GDP, PIC/s GDP, and KGSP standards.
• Medical Marketing Solutions (메디컬 마케팅) Multi-channel digital marketing platform optimized for hospitals and clinics, providing advertising products including display ads, search ads, brand halls, webinars, live commerce broadcasts, and SMS/email marketing targeting BluePharm Korea's 25,000+ member hospitals.
• BlueFeed (블루피드) Non-face-to-face sales support solution for pharmaceutical company MR representatives, enabling customer management, purchase pattern analysis, schedule management, and real-time communication with hospitals, integrated with BluePharm Korea.
• BlueDoc (블루닥) AI-powered medical staff recruitment and substitute doctor matching platform connecting medical institutions with doctors for hiring, including peer recommendation, doctor experience programs, and AI-based automatic job posting creation.
• Big Data Analytics (빅데이터) Healthcare big data analysis service providing insights based on accumulated drug distribution data from BluePharm Korea platform operations, serving domestic and foreign pharmaceutical companies, manufacturers, and platform operators.

Quantifiable outcome

• 80%+ of primary care clinics in Korea covered by the platform
• +5 more outcomes

Named customers20 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Partnerships

18 partnerships are on record, tiered minor and core.

• BioPlus (바이오플러스)minorChannel Partner/ Reseller/ Distributor · 29 April 2026BlueMTec signed a distribution contract with BioPlus for filler and skin booster products.
• Serafeel (쎄라필)minorChannel Partner/ Reseller/ Distributor · 21 April 2026BlueMTec signed a domestic distribution contract with Serafeel for their product line.
• Silverberry (실버베리)minorStrategic or Co-development Partner · 20 October 2025Silverberry and BlueMTec signed a logistics consignment contract to strengthen pharmaceutical-specific logistics capabilities.
• Hanmi Pharmaceutical (한미약품)coreChannel Partner/ Reseller/ Distributor · 22 July 2025BlueMTec signed a distribution contract with Hanmi Pharmaceutical for 'Obodens' (a cold-chain product), with full supply beginning in July 2025 following cold-chain strengthening efforts.
• MDSquare (엠디스퀘어)minorStrategic or Co-development Partner · 13 November 2024BlueMTec acquired a 16.4% stake in MDSquare, becoming its second-largest shareholder. MDSquare operates non-face-to-face healthcare platforms including 'MDTalk' (non-face-to-face consultation) and 'MDCare' (personalized health management). The investment marks BlueMTec's entry into the B2C digital healthcare market. MDSquare has partnerships with major pharmaceutical companies including Sanofi.
• Sanofi Aventis Korea (사노피 아벤티스 코리아)coreChannel Partner/ Reseller/ Distributor · 30 August 2024Sanofi Aventis Korea and BlueMTec signed a business partnership for strengthened influenza vaccine supply through the BluePharm Korea platform.
• Kyungdong Pharmaceutical (경동제약)minorChannel Partner/ Reseller/ Distributor · 5 August 2024BlueMTec and Kyungdong Pharmaceutical signed an online distribution business agreement for ethical drugs.
• Rowan (로완)minorStrategic or Co-development Partner · 1 August 2024Rowan and BlueMTec signed a business agreement for cooperation in developing digital healthcare solutions.
• Samil Pharmaceutical (삼일제약)minorChannel Partner/ Reseller/ Distributor · 28 June 2024BlueMTec and Samil Pharmaceutical signed an online distribution business agreement for ethical drugs.
• CreaTip (크리에이팁)minorGTM or Marketing Partner · 5 June 2024BlueMTec and CreaTip signed a business partnership for attracting customized advertising from clients.
• Gonggam Plus (공감플러스)minorStrategic or Co-development Partner · 3 June 2024BlueMTec acquired a 31% stake in Gonggam Plus, becoming its second-largest shareholder. Gonggam Plus operates a pharmaceutical delivery service with approximately 100 cold-chain-equipped vehicles and provides comprehensive logistics consulting services. The company has partnerships with major pharmaceutical distributors including Jurlik and has a logistics base in Daegu.
• Humedix (휴메딕스)minorChannel Partner/ Reseller/ Distributor · 14 April 2024BlueMTec and Humedix signed a business partnership to strengthen the aesthetic product lineup.
• Medistaff (메디스태프)minorStrategic or Co-development Partner · 26 March 2024BlueMTec acquired a 17% stake in Medistaff, becoming its second-largest shareholder. Medistaff operates Korea's first doctor-exclusive secure messenger platform with over 40,000 doctor members. The company raised approximately 4.4 billion KRW in total investment from Hana Ventures and others.
• ExoCoBio (엑소코바이오)minorChannel Partner/ Reseller/ Distributor · 15 January 2024BlueMTec and ExoCoBio signed a partnership to strengthen the beauty/aesthetic product lineup.
• MSD Korea (한국MSD)coreChannel Partner/ Reseller/ Distributor · 4 December 2023MSD Korea and BlueMTec agreed to co-distribute two vaccine products (Hepatitis A vaccine Bexsero and MMR2) starting January 2024. This marked the first vaccine co-distribution agreement between a global pharmaceutical company and a distributor in Korea, with products to be supplied through BluePharm Korea.
• BuyMed (바이메드)coreStrategic or Co-development Partner · 4 November 2023BlueMTec signed an MOU with BuyMed (Vietnam) for cooperation in digitizing the Vietnamese hospital/clinic pharmaceutical distribution market. The MOU includes cooperation on platform localization, Korean pharmaceutical exports to Vietnam, and transfer of BlueMTec's cold-chain logistics system. BuyMed operates the Thuocsi.vn B2B pharmaceutical distribution platform and has raised approximately $63.5 million from UOB and Smilegate.
• Na-ui-nakdoctor (나만의닥터)minorStrategic or Co-development Partner · 8 January 2023BlueMTec signed an MOU with Na-ui-nakdoctor (non-face-to-face medical consultation platform) for hospital/clinic efficiency improvement. The agreement enables Na-ui-nakdoctor's hospital/clinic users to access convenient pharmaceutical ordering through BluePharm Korea.
• Medicnc Medigate (주)메디씨엔씨 메디게이트)minorStrategic or Co-development Partner · 1 January 2021Business agreement with Medicnc Medigate for healthcare platform cooperation.

Scale indicators16 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• BuyMed (Thuocsi.vn): Vietnamese B2B pharmaceutical e-commerce and distribution platform (Thuocsi) and explicit Blue M Tech localization partner; operates the same two-sided pharma-supplier-to-clinic marketplace model in a similar regulatory and clinical-customer environment, making it the closest direct international peer.
• Tata 1mg: India's leading online pharmacy and B2B-aligned pharma marketplace combining e-commerce with diagnostics and doctor consultations; comparable to Blue M Tech for combining a transactional pharma platform with broader digital healthcare services in an Asian market.
• PharmEasy: Indian B2B/B2C pharmaceutical e-commerce and clinic diagnostic platform; comparable as a high-growth digital pharma distribution player targeting clinic and consumer demand in an Asia market with fragmented physical distribution.

Broad incumbents

• McKesson: Largest U.S. pharmaceutical wholesaler and healthcare services company; represents the global incumbent archetype of pharma distribution at scale, against which Blue M Tech's Korean platform model can be benchmarked for unit economics and market-share durability.
• Cardinal Health: Major U.S. pharmaceutical distributor with healthcare product and data services; comparable as a broad incumbent that combines drug distribution with adjacent medical-services platforms, analogous to Blue M Tech's marketplace-plus-3PL-plus-data strategy.
• Cencora (formerly AmerisourceBergen): Top-3 U.S. pharmaceutical wholesaler with global specialty/biologics distribution capabilities; comparable as an incumbent pharma distributor that has built specialized cold-chain and specialty-pharma capabilities — the same trajectory Blue M Tech is pursuing in Korea.
• Alibaba Health: Chinese healthcare e-commerce and pharmaceutical distribution arm of Alibaba; comparable as a digital-first pharma-plus-healthcare platform operating across Asia, with similar ambitions to combine marketplace, distribution and ancillary healthcare services.
• JD Health: China's largest online healthcare platform combining B2C/B2B pharmaceutical retail, third-party distribution, and healthcare services; closest large-scale analogue of a platform-led pharma distribution and healthcare services business in Asia.

Regional players

• Zuellig Pharma: Asia's largest pharmaceutical distribution and healthcare services group operating across Southeast Asia; comparable as a regional incumbent whose logistics and distribution footprint Blue M Tech is challenging in adjacent SEA markets through the BuyMed partnership.

Emerging players

• Practo: India-headquartered digital healthcare platform spanning telemedicine, clinic SaaS, and pharmacy partnerships; comparable to Blue M Tech's broader healthcare-stack ambition through BlueDoc and MDSquare, though with a more consumer-telehealth orientation than pharma distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@bluemtec

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blue M Tech